Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
The latest in news from I-MAK experts.
For press inquiries, please contact simon@i-mak.org.
Ford School hosts conversation on drug patent system reform
Why are Drug Prices So High? Investigating the outdated US patent system
Ten years ago, I testified before Congress about drug pricing — and it’s only gotten worse. Here’s what’s wrong, and how we may be able to fix it.
After a pharma lobbying blitz, Congress softens legislation on drug patents
The Health 202: The Supreme Court banned patenting genes. But Congress might change that.
Cornyn to launch bill against ‘patent thickets’
Senate Targets Hoarding of Drug Patents to Deter Competition
Costs for lifesaving drugs have skyrocketed. Experts say ‘over-patenting’ to prevent generic competition is part of the problem
Examining the Truvada #BreakThePatent Debate: Gilead Responds
Why Abbvie May Have A Tough Time Defending Humira’s Price Before Congress